-
Je něco špatně v tomto záznamu ?
Multifunctional Roles of miR-34a in Cancer: A Review with the Emphasis on Head and Neck Squamous Cell Carcinoma and Thyroid Cancer with Clinical Implications
D. Kalfert, M. Ludvikova, M. Pesta, J. Ludvik, L. Dostalova, I. Kholová,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články, přehledy
Grantová podpora
18-03978S
Grantová Agentura České Republiky
18-08-00229
Ministerstvo Zdravotnictví Ceské Republiky
Progres Q28/LF1(UNCE 204013)
Univerzita Karlova v Praze
Progres Q39
Univerzita Karlova v Praze
VTR
Pirkanmaa Cancer Foundation
NLK
Directory of Open Access Journals
od 2011
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
MiR-34a belongs to the class of small non-coding regulatory RNAs and functions as a tumor suppressor. Under physiological conditions, miR-34a has an inhibitory effect on all processes related to cell proliferation by targeting many proto-oncogenes and silencing them on the post-transcriptional level. However, deregulation of miR-34a was shown to play important roles in tumorigenesis and processes associated with cancer progression, such as tumor-associated epithelial-mesenchymal transition, invasion, and metastasis. Moreover, further understanding of miR-34a molecular mechanisms in cancer are indispensable for the development of effective diagnosis and treatments. In this review, we summarized the current knowledge on miR-34a functions in human disease with an emphasis on its regulation and dysregulation, its role in human cancer, specifically head and neck squamous carcinoma and thyroid cancer, and emerging role as a disease diagnostic and prognostic biomarker and the novel therapeutic target in oncology.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20021859
- 003
- CZ-PrNML
- 005
- 20201204093138.0
- 007
- ta
- 008
- 201125s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/diagnostics10080563 $2 doi
- 035 __
- $a (PubMed)32764498
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Kalfert, David $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Motol, 1st Faculty of Medicine, Charles University, 15006 Prague, Czech Republic.
- 245 10
- $a Multifunctional Roles of miR-34a in Cancer: A Review with the Emphasis on Head and Neck Squamous Cell Carcinoma and Thyroid Cancer with Clinical Implications / $c D. Kalfert, M. Ludvikova, M. Pesta, J. Ludvik, L. Dostalova, I. Kholová,
- 520 9_
- $a MiR-34a belongs to the class of small non-coding regulatory RNAs and functions as a tumor suppressor. Under physiological conditions, miR-34a has an inhibitory effect on all processes related to cell proliferation by targeting many proto-oncogenes and silencing them on the post-transcriptional level. However, deregulation of miR-34a was shown to play important roles in tumorigenesis and processes associated with cancer progression, such as tumor-associated epithelial-mesenchymal transition, invasion, and metastasis. Moreover, further understanding of miR-34a molecular mechanisms in cancer are indispensable for the development of effective diagnosis and treatments. In this review, we summarized the current knowledge on miR-34a functions in human disease with an emphasis on its regulation and dysregulation, its role in human cancer, specifically head and neck squamous carcinoma and thyroid cancer, and emerging role as a disease diagnostic and prognostic biomarker and the novel therapeutic target in oncology.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Ludvikova, Marie $u Department of Biology, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic.
- 700 1_
- $a Pesta, Martin $u Department of Biology, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic.
- 700 1_
- $a Ludvik, Jaroslav $u Department of Imaging Methods, University Hospital Pilsen, Faculty of Medicine in Pilsen, Charles University, 32300 Pilsen, Czech Republic.
- 700 1_
- $a Dostalova, Lucie $u Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Motol, 1st Faculty of Medicine, Charles University, 15006 Prague, Czech Republic.
- 700 1_
- $a Kholová, Ivana $u Faculty of Medicine and Health Technology, Tampere University, 33520 Tampere, Finland. Pathology, Fimlab Laboratories, 33520 Tampere, Finland.
- 773 0_
- $w MED00195450 $t Diagnostics (Basel, Switzerland) $x 2075-4418 $g Roč. 10, č. 8 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32764498 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201204093136 $b ABA008
- 999 __
- $a ind $b bmc $g 1591568 $s 1112531
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 10 $c 8 $e 20200805 $i 2075-4418 $m Diagnostics $n Diagnostics $x MED00195450
- GRA __
- $a 18-03978S $p Grantová Agentura České Republiky
- GRA __
- $a 18-08-00229 $p Ministerstvo Zdravotnictví Ceské Republiky
- GRA __
- $a Progres Q28/LF1(UNCE 204013) $p Univerzita Karlova v Praze
- GRA __
- $a Progres Q39 $p Univerzita Karlova v Praze
- GRA __
- $a VTR $p Pirkanmaa Cancer Foundation
- LZP __
- $a Pubmed-20201125